Pear Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pear Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q4 2022.
  • Pear Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2022 was $3.68M, a 99.6% increase year-over-year.
  • Pear Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2022 was $13.5M, a 255% increase year-over-year.
  • Pear Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.5M, a 255% increase from 2021.
  • Pear Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.81M, a 57.8% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $13.5M $3.68M +$1.84M +99.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $11.7M $3.56M +$2.63M +283% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $9.06M $3.39M +$2.81M +492% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $6.25M $2.9M +$2.44M +527% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $3.81M $1.85M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $930K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $572K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $463K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.